About this item:

92 Views | 63 Downloads

Author Notes:

Author for correspondence: Tel.: +1 404 727 8176; Fax: +1 404 727 3988; yyoon5@emory.edu

The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Subjects:

Research Funding:

This work was supported by grants from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI15C2782, HI16C2211), the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MSIP; No. 2015M3A9C6031514), NIDDK (DP3-DK108245) and NHLBI (R01HL127759, R01HL129511).

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Technology
  • Cell & Tissue Engineering
  • Engineering, Biomedical
  • Cell Biology
  • Engineering
  • cell therapy
  • direct reprogramming
  • endothelial cells
  • ETV2
  • pluripotency
  • stem cell
  • transcription factor
  • vascular regeneration
  • vector
  • HUMAN FIBROBLASTS
  • MYOCARDIAL-INFARCTION
  • DEFINED FACTORS
  • CONVERSION
  • ANGIOGENESIS

Direct reprogramming into endothelial cells: a new source for vascular regeneration

Tools:

Journal Title:

Regenerative Medicine

Volume:

Volume 12, Number 4

Publisher:

, Pages 317-320

Type of Work:

Article | Post-print: After Peer Review

Copyright information:

© 2017 Future Medicine Ltd

Export to EndNote